Noise pollution in hospitals – a rising problem

 

London, UK (November 18, 2018) – In an editorial published today in the BMJ, researchers from King’s College London and the University of the Arts London (UAL) argue that it is a worsening problem, with levels regularly exceeding international recommendations. „Even in intensive care units, which cater for the most vulnerable patients, noise levels over 100dB have been measured, the equivalent of loud music through headphones,“ said lead author Dr Andreas Xyrichis.

Noise in hospitals is known to hinder communication among staff, causing annoyance, irritation and fatigue, and detrimentally impact the quality and safety of healthcare. High noise levels and noise-induced stress impact negatively on staff performance and wellbeing, compromising caring behaviour and contributing to burnout.

The team highlight that it can also impact a patients‘ ability to rest, heal and recover, since it has been linked to the development of ICU psychosis, hospitalisation-induced stress, increased pain sensitivity, high blood pressure and poor mental health.

„We know hospital noise has disruptive consequences for sleep – machine sounds in particular have a greater negative effect on arousal than human voices. Post-hospitalisation recovery is also compromised. For example, coronary care patients treated during noisy periods were found to have a higher incidence of rehospitalisation compared to those treated during quieter periods,“ explained Andreas.

Patients report that hospital noise can have a cumulative effect on their hospital experience. Patients who are in hospital for several nights are left feeling trapped and stressed, leading to requests for premature discharge from hospital and heightened risk of trauma and readmission.

The team from King’s and UAL believes that the following areas urgently need to be addressed to ensure significant progress in this slow-moving field:

Noise is often incorrectly associated with high sound pressure levels (SPLs). Dripping taps for example, may register low SPLs yet still be considered noisy. Prioritising SPL reduction does not ensure improved noise perception. Therefore, a new approach is needed, one that views the hospital soundscape as a positive and malleable component of the environment.

There are a number of potential sources of noise in hospitals. Alarms, televisions, rattling trolleys, and ringing phones, as well as staff, visitor, and patient conversations. However, not all of them are perceived as noise by patients – for example, some find the sound of the tea trolley pleasing, associating it with receiving a warm drink. Research has also shown that some ICU patients welcome ringing telephones as a sign that they are not alone. So far ways to measure patients‘ perceptions of noise are limited, and more research investment is needed in this area.

Patients and families need clear information about likely noise levels during admissions, so they are better prepared in advance, and can consider simple solutions such as headphones with their own choice of audio content. Education for staff is also needed, to encourage a culture that considers noise reduction an integral part of safe high quality healthcare.

„Measures to tackle this problem have included ear plugs, noise warning systems, acoustic treatment panels, educational initiatives and noise reduction protocols, which have provided some benefit,“ said Andreas.

„However, so far, patients have been seen as passive recipients of hospital noise rather than active participants in its creation. It is essential that future solutions should have greater patient participation as a key feature.

„Guides about potential ward sounds could also enhance patients‘ understanding of their surroundings and increase relaxation. Sound masking – the addition of background, broadband sound optimised for particular environments to reduce noise-induced disturbance – has also been used widely in open-plan offices for many years and has recently shown promise for improving sleep in hospitals.“

 


King’s College London, 18.11.2018 (tB).

Schlagwörter: ,

MEDICAL NEWS

IU School of Medicine researchers develop blood test for anxiety
COVID-19 pandemic increased rates and severity of depression, whether people…
COVID-19: Bacterial co-infection is a major risk factor for death,…
Regenstrief-led study shows enhanced spiritual care improves well-being of ICU…
Hidden bacteria presents a substantial risk of antimicrobial resistance in…

SCHMERZ PAINCARE

Hydromorphon Aristo® long ist das führende Präferenzpräparat bei Tumorschmerz
Sorgen und Versorgen – Schmerzmedizin konkret: „Sorge als identitätsstiftendes Element…
Problem Schmerzmittelkonsum
Post-Covid und Muskelschmerz
Kopfschmerz bei Übergebrauch von Schmerz- oder Migränemitteln

DIABETES

Wie das Dexom G7 abstrakte Zahlen mit Farben greifbar macht…
Diabetes mellitus: eine der großen Volkskrankheiten im Blickpunkt der Schmerzmedizin
Suliqua®: Einfacher hin zu einer guten glykämischen Kontrolle
Menschen mit Diabetes während der Corona-Pandemie unterversorgt? Studie zeigt auffällige…
Suliqua® zur Therapieoptimierung bei unzureichender BOT

ERNÄHRUNG

Positiver Effekt der grünen Mittelmeerdiät auf die Aorta
Natriumaufnahme und Herz-Kreislaufrisiko
Tierwohl-Fleisch aus Deutschland nur mäßig attraktiv in anderen Ländern
Diät: Gehirn verstärkt Signal an Hungersynapsen
Süßigkeiten verändern unser Gehirn

ONKOLOGIE

Strahlentherapie ist oft ebenso effizient wie die OP: Neues vom…
Zanubrutinib bei chronischer lymphatischer Leukämie: Zusatznutzen für bestimmte Betroffene
Eileiter-Entfernung als Vorbeugung gegen Eierstockkrebs akzeptiert
Antibiotika als Störfaktor bei CAR-T-Zell-Therapie
Bauchspeicheldrüsenkrebs: Spezielle Diät kann Erfolg der Chemotherapie beeinflussen

MULTIPLE SKLEROSE

Multiple Sklerose: Aktuelle Immunmodulatoren im Vergleich
Neuer Biomarker für Verlauf von Multipler Sklerose
Multiple Sklerose: Analysen aus Münster erhärten Verdacht gegen das Epstein-Barr-Virus
Aktuelle Daten zu Novartis Ofatumumab und Siponimod bestätigen Vorteil des…
Multiple Sklerose durch das Epstein-Barr-Virus – kommt die MS-Impfung?

PARKINSON

Meilenstein in der Parkinson-Forschung: Neuer Alpha-Synuclein-Test entdeckt die Nervenerkrankung vor…
Neue Erkenntnisse für die Parkinson-Therapie
Cochrane Review: Bewegung hilft, die Schwere von Bewegungssymptomen bei Parkinson…
Technische Innovationen für eine maßgeschneiderte Parkinson-Diagnostik und Therapie
Biomarker und Gene: neue Chancen und Herausforderungen für die Parkinson-Diagnose…